Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes
Manoj Kumar Mahapatra, Muthukumar Karuppasamy, Biswa Mohan Sahoo
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1007/s11154-021-09699-1
- Published
- Jan 7, 2022
- Venue
- Reviews in Endocrine and Metabolic Disorders
- DOI
- 10.1007/s11154-021-09699-1
- PubMed
- 34993760
- Categories
- Diabetes Treatment and Management
- Provenance
- openalex